{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:40:12Z","timestamp":1770979212031,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1007\/bf02582980","type":"journal-article","created":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T08:50:52Z","timestamp":1172739052000},"page":"215-221","source":"Crossref","is-referenced-by-count":6,"title":["The effect of low-dose interferon treatment on visual evoked potentials"],"prefix":"10.1007","volume":"94","author":[{"given":"Michael","family":"Moschos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanouel","family":"Manesis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthimios","family":"Panagakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Brouzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanos","family":"Hadziyannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Theodossiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02582980_CR1","first-page":"746","volume-title":"Meyler's Side Effects of Drugs","author":"D German","year":"1992","unstructured":"German D, Schopfer K. Interferons. In: Dukes MNG (ed). Meyler's Side Effects of Drugs. Amsterdam: Elsevier Publishing Co, 1992: 746."},{"key":"BF02582980_CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmj.306.6870.107","volume":"306","author":"HLA Janssen","year":"1993","unstructured":"Janssen HLA, Brouwer JT, Nevens F, Sanchez-Tapias JM, Craxi A, Hadziyannis S. Fatal hepatic decompensation associated with interferon alpha. Br Med J 1993; 306: 107\u20138.","journal-title":"Br Med J"},{"key":"BF02582980_CR3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1651-2227.1988.tb10718.x","volume":"77","author":"T Vesikara","year":"1988","unstructured":"Vesikara T, Nuutila A, Cantell K. Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma. Acta Paediatr Scand 1988; 77: 619\u201322.","journal-title":"Acta Paediatr Scand"},{"key":"BF02582980_CR4","first-page":"958","volume":"67","author":"DH Johnson","year":"1983","unstructured":"Johnson DH, Hande KH, Hansworth JD, Greco FA. Neurotoxicity of interferons. Cancer Treat Rep 1983; 67: 958\u201361.","journal-title":"Cancer Treat Rep"},{"key":"BF02582980_CR5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.41.5.672","volume":"41","author":"CA Meyers","year":"1991","unstructured":"Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991; 41: 672\u20136.","journal-title":"Neurology"},{"key":"BF02582980_CR6","first-page":"19","volume":"7","author":"J Born","year":"1989","unstructured":"Born J, Spath-Schwalbe E, Pietrowsky R, Porzolt F, Fehns HL. Neurophysiological effects of recombinant interferon-gamma and-alpha in man. Clin Physiol Biochem 1989; 7: 19\u201327.","journal-title":"Clin Physiol Biochem"},{"key":"BF02582980_CR7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00177432","volume":"6","author":"F Adams","year":"1988","unstructured":"Adams F, Fernandez F, Mavligit G. Interferon induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities. J Neuro Oncol 1988; 6: 355\u20139.","journal-title":"J Neuro Oncol"},{"key":"BF02582980_CR8","first-page":"403","volume":"48","author":"RV Iaffaioli","year":"1990","unstructured":"Iaffaioli RV, Fiorenza L, Davino M, Frasci G, LaMura G, Grossi D. Neurologic effects of long term treatment with low dose alpha 2b interferon. Curr Ther Res 1990; 48: 403\u20138.","journal-title":"Curr Ther Res"},{"key":"BF02582980_CR9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","volume":"111","author":"DR Guyer","year":"1993","unstructured":"Guyer DR, Tiereman J, Yannuzzi LA, et al. Interferon associated retinopathy. Arch Ophthalmol 1993; 111: 350\u20136.","journal-title":"Arch Ophthalmol"},{"key":"BF02582980_CR10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0168-8278(05)80331-9","volume":"21","author":"M Manesis","year":"1994","unstructured":"Manesis M, Petrou C, Brouzas D, Hatziyannis S. Optic tract neuropathy complicating low-dose interferon treatment. J Hepatol 1994; 21: 474\u20137.","journal-title":"J Hepatol"},{"key":"BF02582980_CR11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0002-9394(14)76743-1","volume":"112","author":"WE Fung","year":"1991","unstructured":"Fung WE. Interferon alpha 2a for treatment of age related macular degeneration. Am J. Ophthalmol 1991; 112: 349\u201350.","journal-title":"Am J. Ophthalmol"},{"key":"BF02582980_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0161-6420(94)31349-2","volume":"101","author":"CK Chan","year":"1994","unstructured":"Chan CK, Kempin SJ, Noble SK, Palmer GA. The treatment of neovascular membranes by alpha interferon: an efficacy and toxicity study. Ophthalmology 1994; 101: 289\u2013300.","journal-title":"Ophthalmology"},{"key":"BF02582980_CR13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9394(14)71451-5","volume":"115","author":"MA Thomal","year":"1993","unstructured":"Thomal MA, Ibanez HE. Interferon alpha-2a in the treatment of subfoveal choroidal neovascularization. Am J Ophthalmol 1993; 115: 563\u20138.","journal-title":"Am J Ophthalmol"},{"key":"BF02582980_CR14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0161-6420(93)31467-3","volume":"100","author":"LS Poliner","year":"1993","unstructured":"Poliner LS, Tornambe PE, Michelon PE, Heitzmann JG. Interferon alpha-2a for subfoveal neovascularization, in age-related macular degeneration. Ophthalmology 1993; 100: 1417\u201324.","journal-title":"Ophthalmology"},{"key":"BF02582980_CR15","volume-title":"Medical statistics made easy","author":"FB Pipkin","year":"1984","unstructured":"Pipkin FB. Medical statistics made easy. Edinburgh: Churchill Livingstone, 1984; 75."},{"key":"BF02582980_CR16","first-page":"111","volume":"90","author":"G bauherz","year":"1990","unstructured":"bauherz G, Soeur M, Lustman F. Oculomotor nerve paralysis induced by alpha II-interferon. Acta Neurol Belg 1990; 90: 111\u20134.","journal-title":"Acta Neurol Belg"},{"key":"BF02582980_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0404.1984.tb00801.x","volume":"70","author":"M Farkkila","year":"1984","unstructured":"Farkkila M, Iivanainen N, Roine R, et al. Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta Neurol Scand. 1984; 70: 42\u20136.","journal-title":"Acta Neurol Scand."},{"key":"BF02582980_CR18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0002-9394(14)72859-4","volume":"118","author":"D Quillen","year":"1994","unstructured":"Quillen D, Zurlo J, Cunningham D, Blankenship G. Acute pigment epithelitis and hepatitis C. Am J Ophthalmol 1994; 118: 120\u20131.","journal-title":"Am J Ophthalmol"},{"key":"BF02582980_CR19","unstructured":"Farkkila M, Iivanainen N. Neurotoxicity of interferon treatment. Read before the International Congress on Oncology, Espoo, Finland, June 1988."}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02582980.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02582980\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02582980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T03:43:40Z","timestamp":1558323820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02582980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["BF02582980"],"URL":"https:\/\/doi.org\/10.1007\/bf02582980","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}